These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 12840218

  • 41. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
    Pan MH, Chiou YS, Wang YJ, Ho CT, Lin JK.
    Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
    [Abstract] [Full Text] [Related]

  • 42. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
    Ahmad N, Gupta S, Mukhtar H.
    Arch Biochem Biophys; 2000 Apr 15; 376(2):338-46. PubMed ID: 10775421
    [Abstract] [Full Text] [Related]

  • 43. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H.
    Cancer Res; 2006 Mar 01; 66(5):2500-5. PubMed ID: 16510563
    [Abstract] [Full Text] [Related]

  • 44. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease.
    Adhami VM, Siddiqui IA, Sarfaraz S, Khwaja SI, Hafeez BB, Ahmad N, Mukhtar H.
    Clin Cancer Res; 2009 Mar 15; 15(6):1947-53. PubMed ID: 19276266
    [Abstract] [Full Text] [Related]

  • 45. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N, Cheng P, Mukhtar H.
    Biochem Biophys Res Commun; 2000 Aug 28; 275(2):328-34. PubMed ID: 10964666
    [Abstract] [Full Text] [Related]

  • 46. Induction of apoptosis in human stomach cancer cells by green tea catechins.
    Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, Nakanishi K, Akashi K, Hara Y.
    Oncol Rep; 1998 Aug 28; 5(2):527-9. PubMed ID: 9468594
    [Abstract] [Full Text] [Related]

  • 47. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
    Wang P, Vadgama JV, Said JW, Magyar CE, Doan N, Heber D, Henning SM.
    J Nutr Biochem; 2014 Jan 28; 25(1):73-80. PubMed ID: 24314868
    [Abstract] [Full Text] [Related]

  • 48. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
    Baci D, Bruno A, Cascini C, Gallazzi M, Mortara L, Sessa F, Pelosi G, Albini A, Noonan DM.
    J Exp Clin Cancer Res; 2019 Nov 12; 38(1):464. PubMed ID: 31718684
    [Abstract] [Full Text] [Related]

  • 49. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF, Nogueira-Pangrazi E, Kido LA, Montico F, Arana S, Kumar D, Raina K, Agarwal R, Cagnon VHA.
    J Biomed Sci; 2017 May 12; 24(1):31. PubMed ID: 28499383
    [Abstract] [Full Text] [Related]

  • 50. Green tea and the risk of prostate cancer: A systematic review and meta-analysis.
    Guo Y, Zhi F, Chen P, Zhao K, Xiang H, Mao Q, Wang X, Zhang X.
    Medicine (Baltimore); 2017 Mar 12; 96(13):e6426. PubMed ID: 28353571
    [Abstract] [Full Text] [Related]

  • 51. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro.
    Lyn-Cook BD, Rogers T, Yan Y, Blann EB, Kadlubar FF, Hammons GJ.
    Nutr Cancer; 1999 Mar 12; 35(1):80-6. PubMed ID: 10624710
    [Abstract] [Full Text] [Related]

  • 52. Cancer chemoprevention with green tea catechins: from bench to bed.
    Shirakami Y, Shimizu M, Moriwaki H.
    Curr Drug Targets; 2012 Dec 12; 13(14):1842-57. PubMed ID: 23140294
    [Abstract] [Full Text] [Related]

  • 53. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells.
    Thomas F, Holly JM, Persad R, Bahl A, Perks CM.
    Urology; 2011 Aug 12; 78(2):475.e15-21. PubMed ID: 21676444
    [Abstract] [Full Text] [Related]

  • 54. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
    Ahn WS, Huh SW, Bae SM, Lee IP, Lee JM, Namkoong SE, Kim CK, Sin JI.
    DNA Cell Biol; 2003 Mar 12; 22(3):217-24. PubMed ID: 12804120
    [Abstract] [Full Text] [Related]

  • 55. Green tea and prostate cancer.
    Gupta S, Mukhtar H.
    Urol Clin North Am; 2002 Feb 12; 29(1):49-57, viii. PubMed ID: 12109355
    [Abstract] [Full Text] [Related]

  • 56. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M, Adachi S, Masuda M, Kozawa O, Moriwaki H.
    Mol Nutr Food Res; 2011 Jun 12; 55(6):832-43. PubMed ID: 21538846
    [Abstract] [Full Text] [Related]

  • 57. Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway.
    Rahmani AH, Al Shabrmi FM, Allemailem KS, Aly SM, Khan MA.
    Biomed Res Int; 2015 Jun 12; 2015():925640. PubMed ID: 25977926
    [Abstract] [Full Text] [Related]

  • 58. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE, Ellis LM.
    Br J Cancer; 2001 Mar 23; 84(6):844-50. PubMed ID: 11259102
    [Abstract] [Full Text] [Related]

  • 59. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties.
    Azam S, Hadi N, Khan NU, Hadi SM.
    Toxicol In Vitro; 2004 Oct 23; 18(5):555-61. PubMed ID: 15251172
    [Abstract] [Full Text] [Related]

  • 60. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC, Scandlyn MJ, Rosengren RJ.
    Life Sci; 2006 Nov 17; 79(25):2329-36. PubMed ID: 16945390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.